Estrogen receptor test
Test to determine the presence of estrogen receptors in tissue
Estrogen Receptor Test[edit | edit source]
The estrogen receptor test is a laboratory test used to determine the presence of estrogen receptors (ER) in tissue samples, most commonly in breast cancer tissue. This test is crucial in guiding the treatment of breast cancer, as the presence of estrogen receptors can influence the choice of hormonal therapy.
Background[edit | edit source]
Estrogen receptors are proteins found inside and on the surface of certain cells, including breast cancer cells. These receptors bind to the hormone estrogen, which can promote the growth of cancer cells. The presence of estrogen receptors in cancer cells is a key factor in determining the behavior of the cancer and its response to treatment.
Procedure[edit | edit source]
The estrogen receptor test is typically performed on a sample of tumor tissue obtained through a biopsy or surgery. The most common method used is immunohistochemistry (IHC), which involves staining the tissue with antibodies that bind specifically to estrogen receptors. The stained tissue is then examined under a microscope to assess the presence and quantity of estrogen receptors.
Interpretation[edit | edit source]
The results of the estrogen receptor test are usually reported as a percentage of cells that test positive for estrogen receptors. A tumor is considered "ER-positive" if a significant proportion of the cells contain estrogen receptors. This information is used to predict the tumor's response to endocrine therapy, such as tamoxifen or aromatase inhibitors.
Clinical Significance[edit | edit source]
ER-positive breast cancers are more likely to respond to hormonal therapies that block estrogen's effects or lower estrogen levels in the body. These therapies can slow or stop the growth of ER-positive tumors. In contrast, ER-negative tumors do not rely on estrogen for growth and are less likely to respond to hormonal treatments.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
